Health Insurance Company Files Lawsuit Over Metformin NDMA Problems
A Delaware health insurance company has filed a class action lawsuit against a number of generic metformin manufacturers due to the presence of NDMA; a known cancer-causing agent.
Tag Archives: Aurobindo
-
-
Generic Remeron Recall Issued Over Labeling Error Which Could Result In Overdose
A generic Regeneron recall warns that some bottles contain pills with twice the dose due to a labeling error.
-
Problems At Valsartan Manufacturing Plant Found in New FDA Inspection
Aurobindo reports that the FDA has found more problems at its India production facilities during inspections last month in the wake of valsartan recalls.
-
Valsartan Problems Lead To Warning Letter For Aurobindo
An FDA warning letter to generic valsartan drug manufacturer Aurobindo accuses the company of failures in oversight and quality assurance of its generic drug products.
-
NDEA Contamination Leads To Another Valsartan Recall
Aurobindo is recalling another 80 lots of valsartan and valsartan-combination blood pressure medications due to the presence of potentially cancer-causing impurities.
